The Diagnosis & Management of DMD
It is well-understood that receiving the best care can dramatically improve the quality of life and life expectancy of individuals with Duchenne muscular dystrophy, enabling them to lead fulfilling, independent lives into adulthood. The importance of international care recommendations cannot be underestimated.
In 2010, a consensus document ‘The Diagnosis and management of Duchenne muscular dystrophy’ was published as two editions in the Lancet Neurology in January and February 2010. ‘Diagnosis and management of Duchenne muscular dystrophy’ parts 1 and 2
Updated in 2018!
In 2018, we were delighted to announce a significant update, published this time as three papers in the Lancet Neurology. In particular, these address three new topics in addition to the eight from 2010.
These international publications can be used by doctors, patients and families worldwide as a guide to the treatment that individuals with Duchenne should receive at each stage of the disease. They are also a valuable tool for lobbying at a national level to enable incorporation of these recommendations into national health systems. The guidelines represent real international consensus including both the medical and the patient advocacy perspectives and can be used across the world as a powerful tool to recognize those centres where best practice is already in place and to identify gaps in care.
Part 1: Diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management
Part 3: Primary care, emergency management, psychosocial care, and transitions of care across the lifespan
The Diagnosis and Management of Duchenne Muscular Dystrophy
Bushby K et al.
Part 1: Lancet Neurol. 2010 Jan; 9(1):77-93.
Part 2: Lancet Neurol. 2010 Feb; 9(2):177-189
Links to the same article via the publisher’s website
only accessible with a subscription to the journal